it really is understated that Jazz pharma is following us closely.
and we are one of the only companies that have done a head-to-head with the leading FDA-approved product which is currently making $1B p.a.
- Forums
- ASX - By Stock
- EMD
- Ann: Broker Briefing Presentation
Ann: Broker Briefing Presentation, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $14.12M |
Open | High | Low | Value | Volume |
3.5¢ | 4.4¢ | 3.4¢ | $113.5K | 2.981M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.035 |
2 | 60945 | 0.034 |
1 | 28000 | 0.033 |
1 | 50000 | 0.032 |
5 | 142260 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 40000 | 1 |
0.041 | 19100 | 1 |
0.043 | 12000 | 1 |
0.044 | 84500 | 2 |
0.048 | 74017 | 1 |
Last trade - 15.49pm 12/11/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online